Thompson-Torgerson CS, Holowatz LA, Flavahan NA, Kenney WL. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol 292: H1700-H1705, 2007. First published December 15, 2006; doi:10.1152/ajpheart.01078.2006 is the initial thermoregulatory response to cold exposure and can be elicited through either whole body or localized skin cooling. However, the mechanisms governing local cold-induced VC are not well understood. We tested the hypothesis that Rho kinase participates in local cold-induced cutaneous VC. In seven men and women (20 -27 yr of age), up to four ventral forearm skin sites were instrumented with intradermal microdialysis fibers for localized drug delivery during cooling. Skin blood flow was monitored at each site with laserDoppler flowmetry while local skin temperature was decreased and maintained at 24°C for 40 min. Cutaneous vascular conductance (CVC; laser-Doppler flowmetry/mean arterial pressure) was expressed as percent change from 34°C baseline. During the first 5 min of cooling, CVC decreased at control sites (lactated Ringer solution) to Ϫ45 Ϯ 6% (P Ͻ 0.001), increased at adrenoceptor-antagonized sites (yohimbine ϩ propranolol) to 15 Ϯ 14% (P ϭ 0.002), and remained unchanged at both Rho kinase-inhibited (fasudil) and adrenoceptor-antagonized ϩ Rho kinase-inhibited sites (yohimbine ϩ propranolol ϩ fasudil) (Ϫ9 Ϯ 1%, P ϭ 0.4 and Ϫ6 Ϯ 2%, P ϭ 0.4, respectively). During the last 5 min of cooling, CVC further decreased at all sites when compared with baseline values (control, Ϫ77 Ϯ 4%, P Ͻ 0.001; adrenoceptor antagonized, Ϫ61 Ϯ 3%, P Ͻ 0.001; Rho kinase inhibited, Ϫ34 Ϯ 7%, P Ͻ 0.001; and adrenoceptor antagonized ϩ Rho kinase inhibited sites, Ϫ35 Ϯ 3%, P Ͻ 0.001). Rho kinase-inhibited and combined treatment sites were significantly attenuated when compared with both adrenoceptor-antagonized (P Ͻ 0.01) and control sites (P Ͻ 0.0001). Rho kinase mediates both earlyand late-phase cold-induced VC, supporting in vitro findings and providing a putative mechanism through which both adrenergic and nonadrenergic cold-induced VC occurs in an in vivo human thermoregulatory model. fasudil; local cooling; vascular function; adrenergic; norepinephrine CUTANEOUS VASOCONSTRICTION (VC) is the initial thermoregulatory response to defend against cold exposure, effectively minimizing heat loss to the environment. Whole body skin cooling evokes reflex VC, which involves the release of norepinephrine and sympathetic cotransmitters from sympathetic adrenergic axon terminals (38 -40, 42), whereas localized cooling of the cutaneous blood vessels and surrounding tissue engages local (i.e., nonreflex) VC mechanisms that are mediated, in part, by ␣ 2 -adrenoceptors (12,14,27,34). Reflex and local VC are not mutually exclusive responses and often operate in concert during cold exposure to maximize VC (1). However, whereas reflex VC mechanisms are relatively well understood, the mechanisms that govern local cold-induced VC have not been fully elucidated.Localized ...